Clinical Consequences of Generic Warfarin Substitution: An Ecological Study
Authors:
- J. Michael PatersonJPJ. Michael Paterson
- Muhammad MamdaniMMMuhammad Mamdani
- David N. JuurlinkDJDavid N. Juurlink
- Gary NaglieGNGary Naglie
- Andreas LaupacisALAndreas Laupacis
- Thérèse A. StukelTSThérèse A. Stukel
- 25 October 2006
- journal article
- letter
- Published by American Medical Association (AMA)
- Vol. 296 (16) , 1966-1972
Abstract
To the Editor: Generic substitution policies are financially attractive.1 Although several studies have found no clinically important effects of switching to generic warfarin formulations,2 some observational studies have found an increase in warfarin dosages3 or frequent and substantial changes in international normalized ratio (INR).4 Few studies have been sufficiently large to examine clinical outcomes, and none have done so in a large-population setting.Keywords
This publication has 7 references indexed in Scilit:
- Accuracy of coding for possible warfarin complications in hospital discharge abstractsThrombosis Research, 2006
- Potential Savings from Substituting Generic Drugs for Brand-Name Drugs: Medical Expenditure Panel Survey, 1997–2000Annals of Internal Medicine, 2005
- Generic Warfarin: Implications for Clinical Practice and Perceptions of Anticoagulation ProvidersSeminars in Thrombosis and Hemostasis, 2004
- Increased warfarin doses and decreased international normalized ratio response after nationwide generic switchingClinical Pharmacology & Therapeutics, 2003
- Evaluation of the Clinical and Economic Impact of a Brand Name—to‐Generic Warfarin Sodium Conversion ProgramPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2003
- Validity of Stroke Diagnosis on Hospital Discharge Records in Saskatchewan, Canada: Implications for Stroke SurveillanceCerebrovascular Diseases, 1999
- Positive Predictive Value of ICD-9 Codes in the Identification of Cases of Complicated Peptic Ulcer Disease in the Saskatchewan Hospital Automated DatabaseEpidemiology, 1996